Skip to content

Effect of vitamin C on the healing of pressure sores in patients

Effectiveness of Ascorbic Acid in pressure injuries: randomized clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-8ny7zc2
Enrollment
100
Registered
2026-06-30
Start date
2026-06-30
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ascorbic Acid Pressure Ulcer

Interventions

This is a randomized, controlled, two-arm, parallel, single-blind (evaluator-blinded) clinical trial that will assess the effectiveness of topical ascorbic acid in the healing of pressure injuries. El
s routine. Blinding will be simple, with t

Sponsors

Universidade Federal Rural da Amazonia
Lead Sponsor
Instituto de Ciências da Saúde da Universidade Federal do Pará
Collaborator

Eligibility

Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: Individuals of both sexes; between 18 and 90 years; no history of allergy to Ascorbic Acid; under home care; with Stage II or III Pressure Injury; and a score of 15 on the Pressure Ulcer Scale for Healing (PUSH)

Exclusion criteria

Exclusion criteria: Volunteers with pressure injuries in stages other than II or III; presence of uncontrolled systemic or local infection in the injury; concomitant use of topical or systemic therapies that may interfere with the healing process; severe or decompensated clinical conditions that prevent home follow-up; communication difficulties that make data collection impossible; absence of a caregiver when necessary for managing the injury

Design outcomes

Primary

MeasureTime frame
o evaluate the effectiveness of 10% topical ascorbic acid in the healing of pressure sores. A reduction in the time to complete wound healing is expected in the intervention group compared to the control group. This will be verified through systematic clinical follow-up and serial assessment of the lesions. The total time, in days, until complete wound healing will be observed, considering total epithelialization without exudate, as well as the proportion of healed lesions at the end of up to 8 weeks of follow-up.

Secondary

MeasureTime frame
Evaluate the evolution of tissue in the wound bed. A faster improvement in tissue pattern (granulation and epithelialization) is expected in the intervention group. This will be verified through standardized clinical assessment. The percentage of granulation and epithelialization tissue will be observed over time. ;Evaluate the depth of pressure injuries. A more significant reduction in depth is expected in the intervention group. This will be verified through measurement with an appropriate sterile instrument. The value in centimeters of the lesion depth will be observed throughout the follow-up period.

Countries

BR

Contacts

Public ContactVinicius Lino Souza Neto

Universidade Federal Rural da Amazonia

vinolino@hotmail.com+55 (84) 998541996

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Aug 10, 2026